TYNDALL CAPITAL PARTNERS L P

13D and 13G Filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. The latest filing for each security since 12/18/2024, newest first.

Issuer % of Class Filed
Cyclerion Therapeutics, Inc. 13G/A
CYCN · 23255M204
4.8% 8/14/2025
Event 6/30/2025